Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Farnesoid X receptor: from structure to potential clinical applications.

× No keyword cloud information.

27 in total

1. Bile acids via FXR initiate the expression of major transporters involved in the enterohepatic circulation of bile acids in newborn mice.

Authors: Julia Yue Cui; Lauren M Aleksunes; Yuji Tanaka; Zidong Donna Fu; Ying Guo; Grace Liejun Guo; Hong Lu; Xiao-Bo Zhong; Curtis D Klaassen
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-01-19 Impact factor: 4.052

2. Blinded evaluation of farnesoid X receptor (FXR) ligands binding using molecular docking and free energy calculations.

Authors: Edithe Selwa; Eddy Elisée; Agustin Zavala; Bogdan I Iorga
Journal: J Comput Aided Mol Des Date: 2017-09-02 Impact factor: 3.686

3. Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer Partner.

Authors: Xian Pan; Yoon-Kwang Lee; Hyunyoung Jeong
Journal: Drug Metab Dispos Date: 2015-04-29 Impact factor: 3.922

4. Synthesis and Biological Evaluation of a Series of Bile Acid Derivatives as FXR Agonists for Treatment of NASH.

Authors: Hualing Xiao; Peng Li; Xiaolin Li; Haiying He; Jianhua Wang; Fengxun Guo; Jiliang Zhang; Luxia Wei; Hongmei Zhang; Yueyuan Shi; Lijuan Hou; Liang Shen; Zhengxia Chen; Chunyan Du; Shouliang Fu; Pengtao Zhang; Fei Hao; Ping Wang; Deming Xu; Wei Liang; Xin Tian; Aiming Zhang; Xingdong Cheng; Ling Yang; Xiangjian Wang; Xiquan Zhang; Jian Li; Shuhui Chen
Journal: ACS Med Chem Lett Date: 2017-10-31 Impact factor: 4.345

5. Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acids.

Authors: Pablo M González; Carlos F Lagos; Weslyn C Ward; James E Polli
Journal: Mol Pharm Date: 2013-12-26 Impact factor: 4.939

6. Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor.

Authors: Donna D Yu; Wenwei Lin; Barry M Forman; Taosheng Chen
Journal: Bioorg Med Chem Date: 2014-04-16 Impact factor: 3.641

Review 7. Primary sclerosing cholangitis.

Authors: Marina G Silveira; Keith D Lindor
Journal: Can J Gastroenterol Date: 2008-08 Impact factor: 3.522

8. Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery.

Authors: Donna D Yu; Wenwei Lin; Taosheng Chen; Barry M Forman
Journal: Bioorg Med Chem Date: 2013-05-07 Impact factor: 3.641

Review 9. Endocrine functions of bile acids.

Authors: Sander M Houten; Mitsuhiro Watanabe; Johan Auwerx
Journal: EMBO J Date: 2006-03-16 Impact factor: 11.598

Review 10. Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors: Gernot Zollner; Michael Trauner
Journal: Br J Pharmacol Date: 2009-01 Impact factor: 8.739